Biogen Lowers FY2026 Adj EPS Guidance from $14.25-$15.25 to $12.00-$13.00 vs $12.83 Est
Biogen (NASDAQ: BIIB ) lowers FY2026 Adj EPS guidance from $14.25-$15.25 to $12.00-$13.00 vs $12.83 analyst estimate..
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.